State board recommends medical marijuana for anxiety, Tourette syndrome | TribLIVE.com
Pennsylvania

State board recommends medical marijuana for anxiety, Tourette syndrome

Jacob Tierney
719148_web1_web-marijuana5

Pennsylvanians with anxiety and Tourette syndrome could soon be eligible for medical marijuana.

The state Medical Marijuana Advisory Board voted Friday to recommenced adding both conditions to the list of health problems that can qualify patients for the program, according to the state Department of Health.

They would be the first new conditions since the original 21 that were approved in 2016.

State Secretary of Health Rachel Levine will need to approve the changes before they take effect.

Levine will review medical research about marijuana’s effectiveness in treating anxiety and Tourette syndrome before making her decision, according to the DOH.

In a separate vote, the board recommended marijuana edibles — food and drink products laced with marijuana — be approved for sale at dispensaries.

These edibles would require “robust labeling and warnings in order to deter accidental use by children,” DOH spokesman Nate Wardle said via email.

This may not happen for a while, as allowing edibles would require a vote by the state legislature.

The state has taken several steps to broaden access to medical marijuana program since the program’s 2018 launch.

In April, the state approved the sale of dry leaf marijuana.

In December, the Medical Marijuana Advisory Board announced it would accept petitions to consider new qualifying medical conditions.

Anxiety and Depression were among the first petitions to be discussed.

The board rejected six others, including insomnia, irritable bowel syndrome and Addison’s disease, the Allentown Morning Call reported.

These petitions were rejected because of a lack of of specificity in the applications, or a lack of evidence of marijuana’s effectiveness in treating the conditions, according to the Morning Call.

These conditions could be reconsidered later.

More than 100,000 people have signed up for the state’s medical marijuana program.


Jacob Tierney is a Tribune-Review staff writer. You can contact Jacob at 724-836-6646, [email protected] or via Twitter @Soolseem.


Jacob Tierney is a Tribune-Review staff writer. You can contact Jacob at 724-836-6646, [email protected] or via Twitter .

Categories: News | Pennsylvania
TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.